ANTI-P300

ANTI-P300 Suppliers list
Company Name: Merck KGaA  
Tel: 21-20338288
Email: ordercn@merckgroup.com
Company Name: Riedel-de Haen AG  
Tel: 800 558-9160
Email:
Company Name: Alexis Corporation  
Tel: +41 61 926 8989
Email: alexis-ch@alexis-corp.ch
Company Name: Nacalai Tesque, Inc.  
Tel: 81 75 251 1723
Email: info-tech@nacalai.co.jp
Company Name: Upstate  
Tel: 434 975 4300
Email: info@upstate.com
ANTI-P300 Basic information
Product Name:ANTI-P300
Synonyms:P300 (AB-1) MONOCLONAL ANTIBODY;Monoclonal Anti-EP300 antibody produced in mouse;ANTI-HUMAN P300;ANTI-P300 CT;ANTI-P300, HUMAN;ANTI-P300 MOUSE MAB;ANTI-P300;ANTI-P300(AB-1)
CAS:
MF:
MW:0
EINECS:
Product Categories:
Mol File:Mol File
ANTI-P300 Structure
ANTI-P300 Chemical Properties
storage temp. -20°C
form buffered aqueous solution
biological sourcemouse
Safety Information
Storage Class10 - Combustible liquids
MSDS Information
ANTI-P300 Usage And Synthesis
UsesThis gene encodes the adenovirus E1A-associated cellular p300 transcriptional co-activator protein. It functions as histone acetyltransferase that regulates transcription via chromatin remodeling and is important in the processes of cell proliferation and differentiation. It mediates cAMP-gene regulation by binding specifically to phosphorylated CREB protein. This gene has also been identified as a co-activator of HIF1A (hypoxia-inducible factor 1 alpha), and thus plays a role in the stimulation of hypoxia-induced genes such as VEGF. Defects in this gene are a cause of Rubinstein-Taybi syndrome and may also play a role in epithelial cancer. (provided by RefSeq)
Biological ActivityE1A binding protein p300 (p300) and CBP (CREB binding protein) are highly related transcriptional coactivators. Both proteins have been identified through protein interaction assays. In addition to interacting with a variety of cellular factors and oncoproteins, loss of the wild type CBP alleles in isolated tumors suggests th at CBP/p300 might serve as tumor suppressors. The ability of p300 to acetylate many transcription factors, including tumor suppressor p53, E2 factor (E2F), transcription factors II E and -F (TFIIE and -F) etc. demonstrates a novel mechanism of targeted p300 regulation of gene expression. Mutations in the gene encoding the protein have been linked to Rubinstein-Taybi syndrome (RSTS).
ANTI-P300 Preparation Products And Raw materials
Tag:ANTI-P300 Related Product Information